The neuroprotective benefits of α7nAChRs activation and its downstream-mediated cholinergic signaling in brain disorders are inferred mainly from in-vivo studies (Egea et al. 2015; Navarro et al. 2021; Xu et al. 2021; Liu et al. 2023). The gene discussed is CHRNA7; the disease is brain disorder.